America February 24, 2025
GSK Completes Acquisition of IDRx
Pharmaceutical giant GSK has officially sealed its acquisition of biopharma company IDRx Inc. in a high-stakes $1.15 billion deal aimed…
America February 24, 2025
Pharmaceutical giant GSK has officially sealed its acquisition of biopharma company IDRx Inc. in a high-stakes $1.15 billion deal aimed…
By Rihem Akkouche
America October 4, 2024
British consumer healthcare giant Haleon plc announced on Friday that it will invest roughly $637 million to significantly increase its…
By USA Herald
America July 30, 2024
GlaxoSmithKline announced Monday it will invest up to $7.2 billion in a biotech venture capital firm’s research and development pipeline,…
By Rihem Akkouche
America June 5, 2024
Lawsuits claiming Zantac and its generic equivalents caused cancer belong in Connecticut state court, two groups of Constitution State cancer…
By Rochdi Rais
America June 2, 2024
A Delaware judge has allowed more than 70,000 lawsuits regarding the discontinued heartburn drug Zantac to move forward. This decision,…
By Rihem Akkouche
America January 17, 2024
In a strategic financial move, pharmaceutical powerhouse GSK (formerly GlaxoSmithKline) announced on Wednesday that it has successfully divested a significant…
By Rihem Akkouche
America January 9, 2024
In a bold move to bolster its respiratory treatments arsenal, GSK PLC, the British pharmaceutical giant, announced a groundbreaking deal…
By Rihem Akkouche